FIGO Staging – Simplified Gynecologic Cancer Extent Calculator

The FIGO staging system is a set of international rules for describing how far a gynecologic cancer has spread. It’s maintained by the International Federation of Gynecology and Obstetrics (FIGO) and is used alongside TNM staging for cancers of the ovary/fallopian tube/peritoneum, endometrium, cervix, vulva, and vagina.

FIGO Staging – Gynecologic Cancers (Simplified)

FIGO Staging – Gynecologic Cancers (Simplified)

Educational tool to approximate FIGO stage groups (I–IV) for ovarian, endometrial, and cervical cancers based on overall extent of disease. For trained health professionals only.

⚠️ Clinical caution This is a simplified, stage-group calculator only. It does not capture all FIGO sub-stages or recent molecular refinements. Actual staging must use full FIGO criteria, imaging, pathology, and multidisciplinary review. Do not use this tool alone for formal staging or treatment decisions.
General FIGO stage-group logic (simplified):
  • Stage I – Tumor confined to the organ of origin.
  • Stage II – Direct extension into adjacent pelvic organs / tissues.
  • Stage III – Regional spread (e.g. pelvic/para-aortic nodes, pelvic/abdominal peritoneum).
  • Stage IV – Invasion of bladder/rectal mucosa and/or distant metastases.
Choose the main site being staged. Criteria are simplified summaries of the corresponding FIGO systems.
Ovarian / fallopian tube / primary peritoneal cancer (FIGO 2014 – highly simplified)
Endometrial cancer (FIGO 2009 / 2023 – stage groups, simplified)
Cervical cancer (FIGO 2018 – stage groups, simplified)
Pick the single description that best fits the overall extent at diagnosis (simplified approximation only).

Stage Group & Interpretation

Select the cancer type and the best-fitting extent description, then click “Calculate FIGO Stage Group” to see the simplified stage and narrative interpretation.

This tool is intended purely as an educational adjunct for clinicians already familiar with FIGO staging. It approximates stage groups only and does not substitute for full staging guidelines, multidisciplinary discussion, or national/international protocols. It must not be used by patients or families for self-staging or prognosis.

Author

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top